Medicare Enrolled

Dr. William Velasquez, M. D.

Medical Oncology · Houston, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
7737 SOUTHWEST FWY, Houston, TX 77074
7137780300
In practice since 2006 (20 years)
NPI: 1346201175 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Velasquez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Velasquez? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Velasquez

Dr. William Velasquez is a medical oncology specialist in Houston, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Velasquez performed 26,655 Medicare services across 627 unique beneficiaries.

Between the years covered by Open Payments, Dr. Velasquez received a total of $378,907 from 93 pharmaceutical and/or device companies across 1403 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Velasquez is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 33% volume in TX $378,907 industry payments

Medicare Practice Summary

Medicare Utilization ↗
26,655
Medicare services
Top 33% in TX for medical oncology
627
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,333 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Darbepoetin injection (Aranesp) for anemia 23,400 $2 $13
Contrast dye for imaging (iodine-based) 1,700 $0 $0
Complete blood count (CBC) with differential 575 $8 $24
Office visit, established patient (30-39 min) 341 $85 $389
Office visit, established patient, complex (40-54 min) 133 $140 $573
Drug injection, under skin or into muscle 120 $11 $52
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 72 $22 $92
Administration of chemotherapy into vein, 1 hour or less 68 $99 $421
Hospital follow-up visit, high complexity 63 $95 $352
Blood draw (venipuncture) 60 $8 $9
New patient office visit, complex (60-74 min) 24 $171 $671
New patient office visit (45-59 min) 22 $129 $510
CT scan of abdomen and pelvis with contrast 19 $176 $1,020
Stool analysis for blood, by peroxidase activity 19 $4 $13
Ct scan of chest with contrast 13 $51 $599
Nuclear medicine study from skull base to mid-thigh with ct scan 13 $1,193 $5,548
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 13 $101 $356
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
95.0% medium
4.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$378,907
Total received (2018-2024)
Avg $54,130/year across 7 years
Top 4% in TX for medical oncology
93
Companies
1,403
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$313,099 (82.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$45,774 (12.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,035 (5.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$10,442
2023
$8,837
2022
$29,603
2021
$16,123
2020
$27,362
2019
$115,371
2018
$171,171

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Ipsen Biopharmaceuticals, Inc
$76,572
Janssen Biotech, Inc.
$64,832
Janssen Scientific Affairs, LLC
$58,463
Celgene Corporation
$56,621
Amgen Inc.
$38,679
E.R. Squibb & Sons, L.L.C.
$21,542
Gilead Sciences, Inc.
$9,228
Seattle Genetics, Inc.
$6,226
Coherus Biosciences Inc.
$5,779
Genentech USA, Inc.
$4,613
PFIZER INC.
$4,381
AstraZeneca Pharmaceuticals LP
$4,208
CTI BioPharma Corp.
$3,161
GlaxoSmithKline, LLC.
$3,066
Spectrum Pharmaceuticals Inc.
$2,982
Karyopharm Therapeutics Inc.
$2,920
Exelixis Inc.
$2,731
Novartis Pharmaceuticals Corporation
$2,101
Merck Sharp & Dohme LLC
$950
GENZYME CORPORATION
$677
Takeda Pharmaceuticals U.S.A., Inc.
$555
Lilly USA, LLC
$473
Incyte Corporation
$458
Pharmacyclics LLC, An AbbVie Company
$451
Eisai Inc.
$419
Merck Sharp & Dohme Corporation
$414
BeiGene USA, Inc.
$366
Seagen Inc.
$348
Kite Pharma, Inc.
$347
Regeneron Healthcare Solutions, Inc.
$272
Astellas Pharma US Inc
$259
Daiichi Sankyo Inc.
$254
Rigel Pharmaceuticals, Inc.
$242
JAZZ PHARMACEUTICALS INC.
$233
Janssen Pharmaceuticals, Inc
$223
SpringWorks Therapeutics, Inc.
$185
ARRAY BIOPHARMA INC
$176
Taiho Oncology, Inc.
$171
Boston Scientific Corporation
$162
Sirtex Medical Inc
$154
Deciphera Pharmaceuticals Inc.
$136
EUSA Pharma (US) LLC
$133
Adaptive Biotechnologies Corporation
$130
Horizon Pharma plc
$123
NESTLE HEALTHCARE NUTRITION INC.
$123
Pharmacyclics LLC, an AbbVie Company
$122
SOBI, INC
$118
ABBVIE INC.
$103
Bayer HealthCare Pharmaceuticals Inc.
$99
TerSera Therapeutics LLC
$92
Blueprint Medicines Corporation
$88
Puma Biotechnology, Inc.
$87
Secura Bio, Inc.
$83
Bayer Healthcare Pharmaceuticals Inc.
$82
Helsinn Therapeutics (U.S.), Inc.
$81
Teva Pharmaceuticals USA, Inc.
$80
EMD Serono, Inc.
$80
Myriad Genetic Laboratories, Inc.
$79
Agios Pharmaceuticals, Inc.
$75
ADC Therapeutics America, Inc.
$64
EISAI INC.
$62
Clovis Oncology, Inc.
$62
PharmaEssentia USA Corporation
$56
Pharming Healthcare, Inc.
$55
Stemline Therapeutics Inc.
$51
TG THERAPEUTICS, INC.
$50
Acrotech Biopharma LLC
$48
SERVIER PHARMACEUTICALS LLC
$47
Kyowa Kirin, Inc.
$45
AVEO Pharmaceuticals, Inc.
$36
Aurobindo Pharma USA, Inc.
$36
Mirati Therapeutics, Inc.
$34
Pharmacosmos Therapeutics Inc.
$29
Clarus Therapeutics Inc.
$27
AbbVie Inc.
$27
Amneal Pharmaceuticals LLC
$26
AMAG Pharmaceuticals, Inc.
$25
Alexion Pharmaceuticals, Inc.
$25
Dova Pharmaceuticals
$23
UROGEN PHARMA, INC.
$23
Verity Pharmaceuticals Inc.
$22
Sumitomo Pharma America, Inc.
$22
Mylan Institutional Inc.
$21
Octapharma USA, Inc.
$21
TESARO, Inc.
$21
PUMA BIOTECHNOLOGY, INC.
$21
Genmab U.S., Inc.
$18
Sysmex Inostics Inc
$18
AbbVie, Inc.
$18
Medtronic USA, Inc.
$18
Tempus AI, Inc
$17
Sobi, Inc
$15
Stimwave Technologies Incorporated
$15
Top 3 companies account for 52.7% of total payments
Associated products mentioned in payments ›
ABECMA · ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALOXI · ALUNBRIG · AVASTIN · AYVAKIT · Adcetris · Alecensa · Aranesp · BELEODAQ · BENDEKA · BESREMI · BEXSERO · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · EXKIVITY · Enhertu · Epkinly · Erleada · FARYDAK · FERAHEME · FOTIVDA · FRUZAQLA · Fabhalta · Farydak · Fulphila · GAZYVA · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INLYTA · INQOVI · INREBIC · Imbruvica · JADENU · JAKAFI · JATENZO · JELMYTO · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MYLOTARG · MYRISK · Monoferric · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · OGSIVEO · OJJAARA · ONIVYDE · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OSTEOCOOL RF ABLATION · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PYRUKYND · Padcev · Perjeta · Phesgo · Polivy · Pomalyst · Poteligeo · PreciseTumor · QINLOCK · Quzyttir · REBLOZYL · RUCONEST · RYBREVANT · Revlimid · Rezlidhia · Rituxan · Rubraca · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUTENT · Somatuline Depot · Stivarga · Sylvant · TABRECTA · TALVEY · TASIGNA · TECENTRIQ · TECVAYLI · TEPRO · TIBSOVO · Tavalisse · Tecentriq · TheraSphere Y90 Glass Microspheres 10 GBq · Trelstar · Trodelvy · UKONIQ · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · Vectibix · Venclexta · Vonjo · Vyloy · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xospata · Xtandi · Yescarta · ZEJULA · ZENPEP · ZEPZELCA · ZYTIGA · Zevalin · Zoladex · Zydelig · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (83%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in medical oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for medical oncology in TX.

Equivalent to $1,422 per 100 Medicare services performed
Looking for a medical oncology specialist in Houston?
Compare medical oncologists in the Houston area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists within 10 mi
181
Per 100K population
3.8
County median income
$73,104
Nearest hospital
WEST OAKS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Velasquez is a mixed practice specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 4% of TX peers, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Velasquez experienced with darbepoetin injection (aranesp) for anemia?
Based on Medicare claims data, Dr. Velasquez performed 23,400 darbepoetin injection (aranesp) for anemia services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Velasquez receive payments from pharmaceutical companies?
Yes. Dr. Velasquez received a total of $378,907 from 93 companies across 1,403 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Velasquez's costs compare to other medical oncologists in Houston?
Dr. Velasquez's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Velasquez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →